Clinical outcomes of metastatic urothelial carcinoma pts discontinuing enfortumab vedotin.

Authors: Jasmeet Kaur, Nagendra Dhanikonda, Karthik Devarajan, Fern Anari, Matthew R. Zibelman, Daniel M. Geynisman, Elizabeth R. Plimack, Pooja Ghatalia

Published: 2025-05-28

DOI: 10.1200/jco.2025.43.16_suppl.e16574

Source: Full article

---

Abstract

e16574